Efficacy and Safety of Ticagrelor in Relation to Aspirin Use within the Week Before Randomization in the SOCRATES Trial

Podobne zapisy

• Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
  od: Amarenco, Pierre, i wsp.
  Wydane: (2020)
• The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
  od: Johnston, S Claiborne, i wsp.
  Wydane: (2019)
• Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
  od: Amarenco, Pierre, i wsp.
  Wydane: (2020)
• Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
  od: Johnson, Thomas W., i wsp.
  Wydane: (2020)
• Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
  od: Wang, Yilong, i wsp.
  Wydane: (2019)